Executive Order No. 175, s. 1987 Further Amending Republic Act No. 3720, Entitled “An Act to Ensure the Safety And Purity of Foods, Drugs, and Cosmetics Being Made Available to the Public by Creating the Food and Drug Administration Which Shall Administer And Enforce The Laws Pertaining Thereto”, as Amended, and for Other Purposes.
Country
Type of law
Regulation
Abstract
This Executive Order is formulated to further amend Republic Act No. 3720.
The title of Republic Act No. 3720 is hereby amended to read as follows: “An Act To Ensure The Safety And Purity of Foods and Cosmetics, And The Purity, Safety, Efficacy and Quality of Drugs and Devices Being Made Available To the Public, Vesting The Bureau of Food and Drugs with Authority To Administer And Enforce the Laws Pertaining Thereto, And For Other Purposes”. Section 11 of Republic Act No. 3720 is amended by adding the following subsections: “(j) The manufacture, importation, exportation, sale, offering for sale, distribution, or transfer of any drug or device which is not registered with the Bureau pursuant to this Act. (k) The manufacture, importation, exportation, sale, offering for sale, distribution, or transfer of any drug or device by any person without the license from the Bureau required under this Act. (l) The sale or offering for sale of any drug or device beyond its expiration or expiry date. (m) The release for sale or distribution of a batch of drugs without batch certification when required under Section twenty-two hereof.”
The title of Republic Act No. 3720 is hereby amended to read as follows: “An Act To Ensure The Safety And Purity of Foods and Cosmetics, And The Purity, Safety, Efficacy and Quality of Drugs and Devices Being Made Available To the Public, Vesting The Bureau of Food and Drugs with Authority To Administer And Enforce the Laws Pertaining Thereto, And For Other Purposes”. Section 11 of Republic Act No. 3720 is amended by adding the following subsections: “(j) The manufacture, importation, exportation, sale, offering for sale, distribution, or transfer of any drug or device which is not registered with the Bureau pursuant to this Act. (k) The manufacture, importation, exportation, sale, offering for sale, distribution, or transfer of any drug or device by any person without the license from the Bureau required under this Act. (l) The sale or offering for sale of any drug or device beyond its expiration or expiry date. (m) The release for sale or distribution of a batch of drugs without batch certification when required under Section twenty-two hereof.”
Attached files
Web site
Date of text
Repealed
No
Source language
English
Legislation Amendment
No